Not a good buy right now: price is below the pivot (19.652) with soft momentum and downside-biased pattern odds (next week/month skew negative).
If you must act immediately, the risk/reward is unattractive versus waiting for either (a) a dip closer to support ~18.60 or (b) a reclaim of 19.65–20.00 with improving momentum.
Trend/momentum: MACD histogram is negative (-0.167) but contracting, indicating bearish momentum is easing (stabilization, not a reversal yet).
RSI(6) ~44: neutral-to-weak; not oversold enough to suggest a high-conviction bounce.
Moving averages: converging MAs suggest consolidation/chop rather than a clear uptrend.
Key levels: Pivot 19.652 is immediate “line in the sand.” Support S1 ~18.598 (then S2 ~17.946). Resistance R1 ~20.706 (then R2 ~21.358).
Probabilistic candlestick analogs: suggests mild upside next day (+2.63% chance) but weakness over the next week (-1.83%) and month (-9.19%), aligning with a cautious near-term stance.
Options Data
Bullish
Open Interest Put-Call Ratio
Bullish
Option Volume Put-Call Ratio
Sentiment: OI put/call at 0.56 and volume put/call at 0.17 indicate call-leaning positioning (bullish tilt), but today’s absolute volume is tiny (7 contracts), so conviction is limited.
Volatility: 30D IV ~70.41 vs historical vol ~37.04 implies options are priced rich; market is charging a high premium for uncertainty.
Activity spike: volume vs 30D average is high (20.59x), but from a very low baseline—worth noting, not definitive.
Technical Summary
Sell
3
Buy
10
Positive Catalysts
Hedge funds are buying: reported buying amount up ~119.58% over the last quarter (a meaningful institutional tailwind).
Profitability improved in the latest reported quarter: net income and EPS surged YoY alongside higher gross margin.
Options positioning is call-heavy (OI and volume skew), suggesting bullish speculation/positioning.
Neutral/Negative Catalysts
No news/catalysts in the past week; absent a trigger, the stock can drift with the broader tape (S&P 500 down -0.68% today).
Financial Performance
Latest quarter: 2026/Q3.
Revenue: 293.387M, down -4.05% YoY (demand/top-line pressure).
Net income: 10.802M, up +154.40% YoY (material profitability improvement).
EPS: 0.34, up +142.86% YoY.
Gross margin: 34.89%, up +1.78% YoY (margin expansion is the key positive trend).
Growth
Profitability
Efficiency
Analyst Ratings and Price Target Trends
No analyst rating or price-target change data was provided, so a current Wall Street consensus trend cannot be verified here.
Pros (typical bull view given the data): improving profitability/margins and notable hedge-fund accumulation.
Cons (typical bear view given the data): declining revenue and weak/indecisive technical trend, implying execution risk and limited near-term momentum.
Influential/political trading check: no recent Congress trading data available; insiders reported as neutral with no significant recent trend.
Wall Street analysts forecast MNRO stock price to fall over the next 12 months. According to Wall Street analysts, the average 1-year price target for MNRO is 20 USD with a low forecast of 20 USD and a high forecast of 20 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
1 Analyst Rating
Wall Street analysts forecast MNRO stock price to fall over the next 12 months. According to Wall Street analysts, the average 1-year price target for MNRO is 20 USD with a low forecast of 20 USD and a high forecast of 20 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
0 Buy
1 Hold
0 Sell
Hold
Current: 20.140
Low
20
Averages
20
High
20
Current: 20.140
Low
20
Averages
20
High
20
Wells Fargo
David Lantz
Equal Weight
maintain
$15 -> $18
AI Analysis
2025-10-21
Reason
Wells Fargo
David Lantz
Price Target
$15 -> $18
AI Analysis
2025-10-21
maintain
Equal Weight
Reason
Wells Fargo analyst David Lantz raised the firm's price target on Monro to $18 from $15 and keeps an Equal Weight rating on the shares ahead of quarterly results. The firm models +2% comparable sales in Q2, but expects additional signs of turnaround progress.
Wells Fargo
David Lantz
Equal Weight
maintain
$15 -> $16
2025-05-29
Reason
Wells Fargo
David Lantz
Price Target
$15 -> $16
2025-05-29
maintain
Equal Weight
Reason
Wells Fargo analyst David Lantz raised the firm's price target on Monro to $16 from $15 and keeps an Equal Weight rating on the shares. The bar was low, but the firm attributes Monro outperformance to the positive Q4 comp inflection, accelerating quarter-to-date trends, and color around 4 focus areas for improvement. Wells is reluctant to chase as turnarounds are rarely linear and a heavy lift remains.
Unlock Full Analyst Thesis， Get the complete breakdown of rating reason for MNRO
